Data as of May 22
| -0.12 / -1.60%|
The 5 analysts offering 12-month price forecasts for Synta Pharmaceuticals Corp have a median target of 18.00, with a high estimate of 22.00 and a low estimate of 9.00. The median estimate represents a +143.57% increase from the last price of 7.39.
The current consensus among 8 polled investment analysts is to Buy stock in Synta Pharmaceuticals Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.